Skip to main content
. 2023 Feb 1;28(3):1387. doi: 10.3390/molecules28031387

Table 3.

Antimicrobial activity of the synthetized AgNPs.

Bacterial Species MIC (mg/mL) MIC (µg/mL)
SPA-AgNPs SPR-AgNPs Ciprofloxacin Clotrimazole
S. epidermidis G+ ATCC 12228 0.625 0.156 2.5 -
S. aureus G+ ATCC 25923 0.625 <0.0391 2.5 -
B. subtilis G+ ATCC 6633 2.5 <0.0391 10 -
B. cereus G+ ATCC 10876 1.25 <0.0391 20 -
M. lysodeikticus G+ ATCC 4698 0.625 0.156 <0.3125 -
E. faecalis G+ ATCC 29212 <0.0391 <0.0391 <0.3125 -
S. enteritidis G− ATCC 13076 <0.0391 <0.0391 <0.3125 -
S. typhimurium G− ATCC 14028 2.5 0.156 5 -
E. coli G− ATCC 25922 0.625 2.5 0.625 -
P. aeruginosa G− ATCC 10145 <0.0391 <0.0391 <0.3125 -
K. pneumoniae G− ATCC 70063 0.3125 <0.0391 <0.3125 -
Fungal species
T. longibrachiatum FSB 13 1.25 0.156 - 10
T. harzianum FSB 12 0.3125 0.156 - 20
P. canescens FSB 24 >10 <0.0391 - 2.5
P. cyclopium FSB 23 >10 <0.0391 - <0.0391
D. stemonitis FSB 41 >10 0.625 - 0.625
F. oxysporom FSB 91 >10 5 - <0.0391
A. brasiliensis ATCC 16404 >10 1.25 - 1.25
A. alternata FSB 51 >10 0.3125 - <0.0391
C. albicans ATCC 10259 20 20 - 20

G+, gram-positive bacteria; G−, gram-negative bacteria.